H. Wang, C. A. Liddell, M. M. Coates, M. D. Mooney, C. E. Levitz et al., Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study, Lancet, vol.384, pp.957-979, 2013.

H. B. El-serag, Hepatocellular carcinoma, N Engl J Med, vol.365, pp.1118-1127, 2011.

A. Forner, J. M. Llovet, J. Bruix, and . Hepatocellular, Lancet, vol.379, pp.1245-1255, 2012.

J. M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane et al., Sorafenib in advanced hepatocellular carcinoma, N Engl J Med, vol.359, pp.378-390, 2008.

S. M. Ansell, A. M. Lesokhin, I. Borrello, A. Halwani, E. C. Scott et al., PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma, N Engl J Med, vol.372, pp.311-319, 2015.

J. R. Brahmer, S. S. Tykodi, L. Q. Chow, W. J. Hwu, S. L. Topalian et al., Safety and activity of anti-PD-L1 antibody in patients with advanced cancer, N Engl J Med, vol.366, pp.2455-2465, 2012.

W. H. Fridman, L. Zitvogel, C. Sautes-fridman, and G. Kroemer, The immune contexture in cancer prognosis and treatment, Nat Rev Clin Oncol, 2017.

C. Sautes-fridman, M. Lawand, N. A. Giraldo, H. Kaplon, C. Germain et al., Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention, Front Immunol, vol.7, p.407, 2016.

J. Goc, C. Germain, T. K. Vo-bourgais, A. Lupo, C. Klein et al., Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells, Cancer Res, vol.74, pp.705-715, 2014.

C. Germain, S. Gnjatic, F. Tamzalit, S. Knockaert, R. Remark et al., Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer, Am J Respir Crit Care Med, vol.189, pp.832-844, 2014.

S. Finkin, D. Yuan, I. Stein, K. Taniguchi, A. Weber et al., Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma, Nat Immunol, vol.16, pp.1235-1244, 2015.

, European Association For The Study Of The LEuropean Organisation For RTreatment Of C. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma, J Hepatol, vol.56, pp.908-943, 2012.

G. Amaddeo, Q. Cao, Y. Ladeiro, S. Imbeaud, J. C. Nault et al., Integration of tumour and viral genomic characterizations in HBVrelated hepatocellular carcinomas, Gut, vol.64, pp.820-829, 2015.

S. Roessler, H. L. Jia, A. Budhu, M. Forgues, Q. H. Ye et al., A unique metastasis gene signature enables prediction of tumor relapse in earlystage hepatocellular carcinoma patients, Cancer Res, vol.70, pp.10202-10212, 2010.

H. Imamura, Y. Matsuyama, E. Tanaka, T. Ohkubo, K. Hasegawa et al., Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy, J Hepatol, vol.38, pp.200-207, 2003.

P. Bedossa and T. Poynard, An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group, Hepatology, vol.24, pp.289-293, 1996.

, International Agency for Research on Cancer. WHO classification of tumours of the digestive system, p.417, 2010.

M. Ziol, N. Pote, G. Amaddeo, A. Laurent, J. C. Nault et al., Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance, Hepatology, vol.68, pp.103-112, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01744935

J. Murakami, Y. Shimizu, Y. Kashii, T. Kato, M. Minemura et al., Functional B-cell response in intrahepatic lymphoid follicles in chronic hepatitis C, Hepatology, vol.30, pp.143-150, 1999.

J. Calderaro, B. Rousseau, G. Amaddeo, M. Mercey, C. Charpy et al., Programmed death ligand 1 expression in hepatocellular carcinoma: relationship With clinical and pathological features, Hepatology, vol.64, pp.2038-2046, 2016.

D. Coppola, M. Nebozhyn, F. Khalil, H. Dai, T. Yeatman et al., Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling, Am J Pathol, vol.179, pp.37-45, 2011.

R. Critelli, F. Milosa, F. Faillaci, R. Condello, E. Turola et al., Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study, Cell Death Dis, vol.8, p.3017, 2017.

D. Sia, Y. Jiao, I. Martinez-quetglas, O. Kuchuk, C. Villacorta-martin et al., Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features, Gastroenterology, vol.153, pp.812-826, 2017.

J. Calderaro, G. Couchy, S. Imbeaud, G. Amaddeo, E. Letouze et al., Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification, J Hepatol, 2017.

Y. Hoshida, A. Villanueva, M. Kobayashi, J. Peix, D. Y. Chiang et al., Gene expression in fixed tissues and outcome in hepatocellular carcinoma, N Engl J Med, vol.359, pp.1995-2004, 2008.

S. Nakagawa, L. Wei, W. M. Song, T. Higashi, S. Ghoshal et al., Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition, Cancer Cell, vol.30, pp.879-890, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02312659

F. Posch, K. Silina, S. Leibl, A. Mündlein, H. Moch et al., Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer, Oncoimmunology, vol.18, issue.7, p.1378844, 2017.

K. Silin-ßa, A. Soltermann, F. M. Attar, R. Casanova, Z. M. Uckeley et al., Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma, Cancer Res, vol.78, issue.5, pp.1308-1320, 2018.

D. R. Kroeger, K. Milne, and B. H. Nelson, Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer, Clin Cancer Res, vol.22, pp.3005-3015, 2016.

D. T. Le, J. N. Uram, H. Wang, B. R. Bartlett, H. Kemberling et al., PD-1 blockade in tumors with mismatch-repair deficiency, N Engl J Med, vol.372, pp.2509-2520, 2015.

N. Mcgranahan, A. J. Furness, R. Rosenthal, S. Ramskov, R. Lyngaa et al., Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade, Science, vol.351, pp.1463-1469, 2016.

M. S. Rooney, S. A. Shukla, C. J. Wu, G. Getz, and N. Hacohen, Molecular and genetic properties of tumors associated with local immune cytolytic activity, Cell, vol.160, pp.48-61, 2015.

, Cancer Genome Atlas N. Comprehensive molecular characterization of human colon and rectal cancer, Nature, vol.487, pp.330-337, 2012.